Literature DB >> 18463172

Incidence and outcomes of contrast-induced AKI following computed tomography.

Steven D Weisbord1, Maria K Mor, Abby L Resnick, Kathryn C Hartwig, Paul M Palevsky, Michael J Fine.   

Abstract

BACKGROUND AND OBJECTIVES: Most studies of contrast-induced acute kidney injury (CIAKI) have focused on patients undergoing angiographic procedures. The incidence and outcomes of CIAKI in patients undergoing nonemergent, contrast-enhanced computed tomography in the inpatient and outpatient setting were assessed. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients with estimated glomerular filtration rates (GFRs) <60 ml/min per 1.73 m(2) undergoing nonemergent computed tomography with intravenous iodinated radiocontrast at an academic VA Medical Center were prospectively identified. Serum creatinine was assessed 48 to 96 h postprocedure to quantify the incidence of CIAKI, and the need for postprocedure dialysis, hospital admission, and 30-d mortality was tracked to examine the associations of CIAKI with these medical outcomes.
RESULTS: A total of 421 patients with a median estimated GFR of 53 ml/min per 1.73 m(2) were enrolled. Overall, 6.5% of patients developed an increase in serum creatinine >or=25%, and 3.5% demonstrated a rise in serum creatinine >or=0.5 mg/dl. Although only 6% of outpatients received preprocedure and postprocedure intravenous fluid, <1% of outpatients with estimated GFRs >45 ml/min per 1.73 m(2) manifested an increase in serum creatinine >or=0.5 mg/dl. None of the study participants required postprocedure dialysis. Forty-six patients (10.9%) were hospitalized and 10 (2.4%) died by 30-d follow-up; however, CIAKI was not associated with these outcomes.
CONCLUSIONS: Clinically significant CIAKI following nonemergent computed tomography is uncommon among outpatients with mild baseline kidney disease. These findings have important implications for providers ordering and performing computed tomography and for future clinical trials of CIAKI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463172      PMCID: PMC2518784          DOI: 10.2215/CJN.01260308

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  28 in total

1.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.

Authors:  P A McCullough; R Wolyn; L L Rocher; R N Levin; W W O'Neill
Journal:  Am J Med       Date:  1997-11       Impact factor: 4.965

2.  Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents.

Authors:  R Solomon; C Werner; D Mann; J D'Elia; P Silva
Journal:  N Engl J Med       Date:  1994-11-24       Impact factor: 91.245

3.  A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography.

Authors:  John D Durham; Christopher Caputo; John Dokko; Thomas Zaharakis; Mohsen Pahlavan; Jan Keltz; Paula Dutka; Kevin Marzo; John K Maesaka; Steven Fishbane
Journal:  Kidney Int       Date:  2002-12       Impact factor: 10.612

4.  Contrast nephropathy in patients with impaired renal function: high versus low osmolar media.

Authors:  B J Barrett; P S Parfrey; H M Vavasour; J McDonald; G Kent; D Hefferton; F O'Dea; E Stone; R Reddy; P J McManamon
Journal:  Kidney Int       Date:  1992-05       Impact factor: 10.612

Review 5.  Radiocontrast-induced acute renal failure.

Authors:  Steven D Weisbord; Paul M Palevsky
Journal:  J Intensive Care Med       Date:  2005 Mar-Apr       Impact factor: 3.510

Review 6.  The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients.

Authors:  Richard Solomon
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

7.  A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.

Authors:  M A Stevens; P A McCullough; K J Tobin; J P Speck; D C Westveer; D A Guido-Allen; G C Timmis; W W O'Neill
Journal:  J Am Coll Cardiol       Date:  1999-02       Impact factor: 24.094

Review 8.  Contrast nephrotoxicity.

Authors:  B J Barrett
Journal:  J Am Soc Nephrol       Date:  1994-08       Impact factor: 10.121

9.  PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction.

Authors:  A J Taylor; D Hotchkiss; R W Morse; J McCabe
Journal:  Chest       Date:  1998-12       Impact factor: 9.410

10.  Risks for renal dysfunction with cardiac angiography.

Authors:  C P Taliercio; R E Vlietstra; L D Fisher; J C Burnett
Journal:  Ann Intern Med       Date:  1986-04       Impact factor: 25.391

View more
  49 in total

1.  Radiocontrast-induced acute kidney injury in the ICU: worse than presumed?

Authors:  Michael Joannidis; Christian J Wiedermann
Journal:  Intensive Care Med       Date:  2011-11-03       Impact factor: 17.440

2.  Off-label use of intravascular iodinated organic and MR contrast media.

Authors:  O Tamburrini; I Aprile; C Falcone; D Console; A Rotundo; A Rotondo
Journal:  Radiol Med       Date:  2010-10-27       Impact factor: 3.469

Review 3.  Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?

Authors:  Ulf Nyman; Torsten Almén; Bo Jacobsson; Peter Aspelin
Journal:  Eur Radiol       Date:  2012-02-04       Impact factor: 5.315

Review 4.  Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention.

Authors:  Shu Min Tao; Julian L Wichmann; U Joseph Schoepf; Stephen R Fuller; Guang Ming Lu; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2015-12-18       Impact factor: 5.315

5.  Contrast-induced acute kidney injury: is there a risk after intravenous contrast?

Authors:  Richard Solomon
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-13       Impact factor: 8.237

6.  Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group.

Authors:  Iwao Ohno; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Naoki Kashihara; Hirokazu Okada; Yasuhiro Komatsu; Shozo Tamura; Kazuo Awai; Yasuyuki Yamashita; Ryohei Kuwatsuru; Atsushi Hirayama; Yoshihiko Saito; Toyoaki Murohara; Nagara Tamaki; Akira Sato; Tadateru Takayama; Enyu Imai; Yoshinari Yasuda; Daisuke Koya; Yoshiharu Tsubakihara; Shigeo Horie; Yukunori Korogi; Yoshifumi Narumi; Katsumi Hayakawa; Hiroyuki Daida; Koichi Node; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2013-08       Impact factor: 2.801

7.  Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group.

Authors:  Iwao Ohno; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Naoki Kashihara; Hirokazu Okada; Yasuhiro Komatsu; Shozo Tamura; Kazuo Awai; Yasuyuki Yamashita; Ryohei Kuwatsuru; Atsushi Hirayama; Yoshihiko Saito; Toyoaki Murohara; Nagara Tamaki; Akira Sato; Tadateru Takayama; Enyu Imai; Yoshinari Yasuda; Daisuke Koya; Yoshiharu Tsubakihara; Shigeo Horie; Yukunori Korogi; Yoshifumi Narumi; Katsumi Hayakawa; Hiroyuki Daida; Koichi Node; Isao Kubota
Journal:  Jpn J Radiol       Date:  2013-08       Impact factor: 2.374

Review 8.  Contrast-induced acute kidney injury in interventional cardiology: Emerging evidence and unifying mechanisms of protection by remote ischemic conditioning.

Authors:  Adebayo C Atanda; Oladipupo Olafiranye
Journal:  Cardiovasc Revasc Med       Date:  2017-06-06

9.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

10.  The incidence of contrast-induced nephropathy (CIN) following transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC).

Authors:  Katsumi Hayakawa; Masato Tanikake; Toshihiko Kirishima; Naomi Yoshinami; Hiroyuki Shintani; Eiji Yamamoto; Taisuke Morimoto
Journal:  Eur Radiol       Date:  2014-02-13       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.